Evaluation of colchicine in treatment of coronavirus

Phase 3

Recruiting

• Conditions: Coronavirus infection, unspecified; Pulmonary infection of COVD19.; B34.2

• Registration Number: IRCT20200418047126N1
• Lead Sponsor: Ardabil University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 15 June 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Positive PCR for COVID19

Exclusion Criteria

Sensitivity of patients to any medication that is in the regimen
Renal failure
Heart disease
Pregnancy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hospitalization outcome. Timepoint: Last day of hospitalization in the section. Method of measurement: Calendar.;Fever cessation. Timepoint: Before hospitalization and 1, 3, 5, 7 days after hospitalization. Method of measurement: calendar.;Hospitalization time. Timepoint: First and last day of hospitalization. Method of measurement: Calendar.